BAUSCH + LOMB CORP (BLCO:NYSE)
$14.87 -0.11 (-0.7343%)
Analysed BAUSCH + LOMB CORP (BLCO:NYSE) News Sources
Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference
12-05-2026
yahoo.com
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
13-05-2026
247wallst.com
Bausch + Lomb Corporation (BLCO): Carl C. Icahn Likes This Stock
13-05-2026
yahoo.com
How Investors May Respond To Bausch + Lomb (BLCO) Surgical Launch and EBITDA Momentum
17-05-2026
yahoo.com
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States
19-05-2026
yahoo.com
3 Profitable Stocks We’re Skeptical Of
19-05-2026
yahoo.com
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
20-05-2026
yahoo.com
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
21-05-2026
yahoo.com
Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest
21-05-2026
yahoo.com
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
01-06-2026
yahoo.com
What is the current price of BAUSCH + LOMB CORP (BLCO:NYSE)?
The current price of BAUSCH + LOMB CORP (BLCO:NYSE) is $14.87.
BAUSCH + LOMB CORP (BLCO:NYSE) absolute price change since previous trading day?
The absolute price change of BAUSCH + LOMB CORP (BLCO:NYSE) since the previous trading day is $-0.11.
BAUSCH + LOMB CORP (BLCO:NYSE) percentage price change since previous trading day?
The percentage price change of BAUSCH + LOMB CORP (BLCO:NYSE) since the previous trading day is -0.7343%.
What is the most recent average sentiment score for BAUSCH + LOMB CORP (BLCO:NYSE)?
The most recent average sentiment score for BAUSCH + LOMB CORP (BLCO:NYSE) is 57 out of 100.
What is the most recent average sentiment for BAUSCH + LOMB CORP (BLCO:NYSE)?
The most recent sentiment for BAUSCH + LOMB CORP (BLCO:NYSE) is .
SEC-8K** Filing Available For BAUSCH + LOMB CORP (BLCO:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.